000			01371cam a2200205 4500
001			0123942950
008			171004t2014 xxu||||| |||| 00| 0 eng d
020			_a0123942950
100			_aLattime, Edmund C.
245		0	_aGene therapy of cancer
250			_a3rd ed.
260			_aLondon _bAcademic Press _c2014
520			_aGene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive.
650			_aGENE THERAPY
650			_aGENETICS
650			_aNEOPLASMS
700			_aGerson, Stanton L.
856			_uhttps://www.clinicalkey.com/#!/browse/book/3-s2.0-C2011006951X _y[E-book. Log-in using your OpenAthens account.]
999			_c85168 _d85168